Publication | Closed Access

Effects of Combined Candesartan and ACE Inhibitors on BNP, Markers of Inflammation and Oxidative Stress, and Glucose Regulation in Patients With Symptomatic Heart Failure

Metabolic SyndromeHypertensionHeart FailureAce InhibitorsCombined CandesartanCardiovascular DiseaseMedicineAntihypertensive TherapyDiabetesCardiovascular PharmacologyCardiologyPharmacotherapyCardiovascular FunctionCardiovascular ToxicityPharmacologyAtherosclerosisOxidative Stress